News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
268,103 Results
Type
Article (14251)
Company Profile (281)
Press Release (253571)
Multimedia
Podcasts (48)
Webinars (7)
Section
Business (79532)
Career Advice (152)
Deals (13230)
Drug Delivery (35)
Drug Development (50462)
Employer Resources (31)
FDA (5724)
Job Trends (5133)
News (144436)
Policy (10032)
Tag
Academia (915)
Accelerated approval (2)
Adcomms (12)
Allergies (52)
Alliances (21673)
ALS (64)
Alzheimer's disease (848)
Antibody-drug conjugate (ADC) (100)
Approvals (5752)
Artificial intelligence (124)
Autoimmune disease (18)
Automation (5)
Bankruptcy (105)
Best Places to Work (4559)
BIOSECURE Act (6)
Biosimilars (43)
Biotechnology (232)
Bladder cancer (58)
Brain cancer (20)
Breast cancer (155)
Cancer (1479)
Cardiovascular disease (116)
Career advice (133)
Career pathing (2)
CAR-T (117)
Cell therapy (331)
Cervical cancer (8)
Clinical research (41087)
Collaboration (542)
Compensation (258)
Complete response letters (13)
COVID-19 (1034)
CRISPR (42)
C-suite (164)
Cystic fibrosis (76)
Data (1523)
Denatured (11)
Depression (30)
Diabetes (139)
Diagnostics (1300)
Digital health (3)
Diversity (2)
Diversity, equity & inclusion (9)
Drug discovery (85)
Drug pricing (28)
Drug shortages (3)
Duchenne muscular dystrophy (90)
Earnings (29835)
Editorial (18)
Employer branding (4)
Employer resources (29)
Events (48608)
Executive appointments (464)
FDA (6422)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (498)
Gene editing (97)
Generative AI (10)
Gene therapy (254)
GLP-1 (366)
Government (1080)
Grass and pollen (2)
Guidances (22)
Healthcare (6594)
Huntington's disease (22)
IgA nephropathy (25)
Immunology and inflammation (92)
Indications (20)
Infectious disease (1099)
Inflammatory bowel disease (114)
Inflation Reduction Act (8)
Influenza (19)
Intellectual property (67)
Interviews (17)
IPO (7274)
IRA (11)
Job creations (861)
Job search strategy (127)
Kidney cancer (7)
Labor market (5)
Layoffs (209)
Leadership (3)
Legal (1386)
Liver cancer (33)
Lung cancer (205)
Lymphoma (101)
Machine learning (3)
Management (7)
Manufacturing (140)
MASH (53)
Medical device (2599)
Medtech (2600)
Mergers & acquisitions (6287)
Metabolic disorders (390)
Multiple sclerosis (53)
NASH (13)
Neurodegenerative disease (68)
Neuropsychiatric disorders (25)
Neuroscience (1257)
NextGen: Class of 2025 (2017)
Non-profit (852)
Now hiring (21)
Obesity (194)
Opinion (102)
Ovarian cancer (63)
Pain (43)
Pancreatic cancer (56)
Parkinson's disease (121)
Partnered (8)
Patents (130)
Patient recruitment (78)
Peanut (35)
People (25648)
Pharmaceutical (47)
Pharmacy benefit managers (5)
Phase I (14514)
Phase II (19111)
Phase III (12081)
Pipeline (808)
Policy (45)
Postmarket research (852)
Preclinical (6141)
Press Release (30)
Prostate cancer (62)
Psychedelics (35)
Radiopharmaceuticals (213)
Rare diseases (292)
Real estate (1419)
Recruiting (12)
Regulatory (8641)
Reports (15)
Research institute (938)
Resumes & cover letters (17)
Rett syndrome (4)
RNA editing (5)
RSV (10)
Schizophrenia (60)
Series A (98)
Series B (63)
Service/supplier (1)
Sickle cell disease (40)
Special edition (11)
Spinal muscular atrophy (117)
Sponsored (12)
Startups (1975)
State (1)
Stomach cancer (4)
Supply chain (23)
Tariffs (9)
The Weekly (36)
Vaccines (213)
Venture capitalists (32)
Weight loss (110)
Women's health (15)
Worklife (2)
Date
Today (91)
Last 7 days (509)
Last 30 days (1508)
Last 365 days (19545)
2025 (6281)
2024 (20551)
2023 (22414)
2022 (26823)
2021 (27805)
2020 (23356)
2019 (16223)
2018 (11738)
2017 (13745)
2016 (11839)
2015 (14349)
2014 (10392)
2013 (7484)
2012 (7532)
2011 (7614)
2010 (7428)
Location
Africa (148)
Alabama (42)
Alaska (2)
Arizona (53)
Arkansas (5)
Asia (17315)
Australia (2935)
California (3862)
Canada (1141)
China (360)
Colorado (149)
Connecticut (151)
Delaware (102)
Europe (37247)
Florida (465)
Georgia (116)
Idaho (16)
Illinois (232)
India (10)
Indiana (91)
Iowa (2)
Japan (75)
Kansas (62)
Kentucky (5)
Louisiana (3)
Maine (11)
Maryland (473)
Massachusetts (3082)
Michigan (70)
Minnesota (145)
Mississippi (1)
Missouri (24)
Montana (14)
Nebraska (4)
Nevada (17)
New Hampshire (14)
New Jersey (967)
New Mexico (12)
New York (1045)
North Carolina (553)
North Dakota (5)
Northern California (1702)
Ohio (112)
Oklahoma (9)
Oregon (21)
Pennsylvania (741)
Puerto Rico (6)
Rhode Island (19)
South America (208)
South Carolina (4)
Southern California (1487)
Tennessee (25)
Texas (448)
United States (13267)
Utah (53)
Virginia (79)
Washington D.C. (30)
Washington State (351)
Wisconsin (15)
268,103 Results for "aclaris therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Aclaris Therapeutics Appoints Jesse Hall, M.D. as Chief Medical Officer
April 30, 2025
·
5 min read
Press Releases
Aclaris Therapeutics to Participate in Two March 2025 Healthcare Conferences
March 5, 2025
·
1 min read
Press Releases
Aclaris Therapeutics Announces Formation of New Scientific Advisory Board
January 31, 2025
·
2 min read
Press Releases
Aclaris Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides a Corporate Update
February 27, 2025
·
11 min read
Press Releases
Aclaris Therapeutics Secures U.S. Food and Drug Administration IND Clearance for ATI-052, Enabling Advancement of its Novel Bispecific Anti-TSLP/IL-4R Investigational Antibody
April 22, 2025
·
5 min read
Press Releases
Aclaris Therapeutics Announces $80 Million Private Placement
November 19, 2024
·
3 min read
Pharm Country
Aclaris Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
Aclaris Therapeutics, Inc. today announced that Dr. Neal Walker, Interim President & CEO of Aclaris, will participate in a fireside chat during the Goldman Sachs 45th Annual Global Healthcare Conference on Tuesday, June 11, 2024 at 11:20 AM ET in Miami, Florida.
June 6, 2024
·
1 min read
Press Releases
Aclaris Therapeutics to Participate in the Piper Sandler 36th Annual Healthcare Conference
November 26, 2024
·
1 min read
Press Releases
Aclaris Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - January 6, 2025
January 7, 2025
·
1 min read
Business
Aclaris Therapeutics Reports First Quarter 2024 Financial Results and Provides a Corporate Update
Aclaris Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, announced its financial results for the first quarter of 2024 and provided a corporate update.
May 7, 2024
·
8 min read
1 of 26,811
Next
